SCN1A and Dravet syndrome: For example, an antisense oligonucleotide (ASO)‐based targeted augmentation of nuclear gene output approach has been used to increase the expression of functional NaV1.1 channels in DS mice, observing a substantial decrease in spontaneous seizures and SUDEP when specific ASOs were injected in newborn mice (Han et al., 2020).